Zhe Jiang Li Zi Yuan Food vs Danone SA: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Zhe Jiang Li Zi Yuan Food Co Ltd (605337.CG)

Q3 202629 Jul – 9 Oct 2026

▲2▼2

Liziyuan profit slumps, director probed, but dairy cycle turns up

Raw milk cycle turning up lifts dairy stocks Milk prices are rising and the national dairy herd keeps shrinking, so investors bet the long dairy downturn is ending. Liziyuan shares jumped to their daily limit in a sector-wide rally. If milk prices keep recovering, demand and pricing for dairy drinks should improve, helping the stock.
This is the main positive force behind the stock's move and explains the sector rally it joined.
First-half profit down 32% on weak sales and costs Liziyuan's first-half net profit fell 32.3% to 65 million yuan, revenue slipped 2.7%, and second-quarter profit dropped 61.5%. The company blamed lower sales of milk-containing drinks and higher raw material costs. Weak earnings weigh on the stock because the business is still shrinking.
This is the company's own hard result and the clearest negative driver for the share price.
Big dividend payout cushions weak results Alongside the weak report, Liziyuan plans to pay 1.3 yuan per 10 shares, about 49.8 million yuan, or 76.6% of its profit. Paying out most earnings signals confidence and gives shareholders cash, which supports the stock and softens the blow of falling profit.
It is a concrete shareholder-return action that offsets the negative earnings news.
Independent director under investigation for serious violations Director Xiao Zuoping, who chairs Liziyuan's audit committee, is being investigated for suspected serious disciplinary and legal violations. He also sits on two other listed boards. The company says the case is unrelated to it and won't hurt operations, but an audit-committee head under probe raises governance worries.
It is the newest event and a governance risk that can pressure the stock despite company reassurances.

September 202629 Jul – 9 Oct 2026

▲2▼2

Liziyuan profit slumps, director probed, but dairy cycle turns up

Raw milk cycle turning up lifts dairy stocks Milk prices are rising and the national dairy herd keeps shrinking, so investors bet the long dairy downturn is ending. Liziyuan shares jumped to their daily limit in a sector-wide rally. If milk prices keep recovering, demand and pricing for dairy drinks should improve, helping the stock.
This is the main positive force behind the stock's move and explains the sector rally it joined.
First-half profit down 32% on weak sales and costs Liziyuan's first-half net profit fell 32.3% to 65 million yuan, revenue slipped 2.7%, and second-quarter profit dropped 61.5%. The company blamed lower sales of milk-containing drinks and higher raw material costs. Weak earnings weigh on the stock because the business is still shrinking.
This is the company's own hard result and the clearest negative driver for the share price.
Big dividend payout cushions weak results Alongside the weak report, Liziyuan plans to pay 1.3 yuan per 10 shares, about 49.8 million yuan, or 76.6% of its profit. Paying out most earnings signals confidence and gives shareholders cash, which supports the stock and softens the blow of falling profit.
It is a concrete shareholder-return action that offsets the negative earnings news.
Independent director under investigation for serious violations Director Xiao Zuoping, who chairs Liziyuan's audit committee, is being investigated for suspected serious disciplinary and legal violations. He also sits on two other listed boards. The company says the case is unrelated to it and won't hurt operations, but an audit-committee head under probe raises governance worries.
It is the newest event and a governance risk that can pressure the stock despite company reassurances.

Latest29 Jul – 9 Oct 2026

▲2▼2

Liziyuan profit slumps, director probed, but dairy cycle turns up

Raw milk cycle turning up lifts dairy stocks Milk prices are rising and the national dairy herd keeps shrinking, so investors bet the long dairy downturn is ending. Liziyuan shares jumped to their daily limit in a sector-wide rally. If milk prices keep recovering, demand and pricing for dairy drinks should improve, helping the stock.
This is the main positive force behind the stock's move and explains the sector rally it joined.
First-half profit down 32% on weak sales and costs Liziyuan's first-half net profit fell 32.3% to 65 million yuan, revenue slipped 2.7%, and second-quarter profit dropped 61.5%. The company blamed lower sales of milk-containing drinks and higher raw material costs. Weak earnings weigh on the stock because the business is still shrinking.
This is the company's own hard result and the clearest negative driver for the share price.
Big dividend payout cushions weak results Alongside the weak report, Liziyuan plans to pay 1.3 yuan per 10 shares, about 49.8 million yuan, or 76.6% of its profit. Paying out most earnings signals confidence and gives shareholders cash, which supports the stock and softens the blow of falling profit.
It is a concrete shareholder-return action that offsets the negative earnings news.
Independent director under investigation for serious violations Director Xiao Zuoping, who chairs Liziyuan's audit committee, is being investigated for suspected serious disciplinary and legal violations. He also sits on two other listed boards. The company says the case is unrelated to it and won't hurt operations, but an audit-committee head under probe raises governance worries.
It is the newest event and a governance risk that can pressure the stock despite company reassurances.

Danone SA (BN.PA)

Q3 202622 Jun – 4 Sep 2026

▲4

Danone buys growth brands, beats Q2, strengthens patent

Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.
A concrete deal that adds growth and profit, directly supporting the stock.
Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.
The quarter's results beat expectations and confirm the company is on track.
Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.
A completed deal that expands a fast-growing part of the business.
New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.
Protects a promising new product line, a real positive for future sales.

July 202622 Jun – 4 Sep 2026

▲4

Danone buys growth brands, beats Q2, strengthens patent

Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.
A concrete deal that adds growth and profit, directly supporting the stock.
Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.
The quarter's results beat expectations and confirm the company is on track.
Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.
A completed deal that expands a fast-growing part of the business.
New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.
Protects a promising new product line, a real positive for future sales.

Latest22 Jun – 4 Sep 2026

▲4

Danone buys growth brands, beats Q2, strengthens patent

Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.
A concrete deal that adds growth and profit, directly supporting the stock.
Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.
The quarter's results beat expectations and confirm the company is on track.
Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.
A completed deal that expands a fast-growing part of the business.
New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.
Protects a promising new product line, a real positive for future sales.